Korean J Pain.  2014 Jul;27(3):297-300. 10.3344/kjp.2014.27.3.297.

The Long-Term Safety and Efficacy of Intrathecal Therapy Using Sufentanil in Chronic Intractable Non-Malignant Pain

• Monsivais
• Monsivais

• KMID: 2278244
• DOI: http://doi.org/10.3344/kjp.2014.27.3.297

Abstract

This report describes the long term safety and efficacy of intrathecal therapy using Sufentanil for the management of chronic intractable neuropathic pain in 12 chronic pain patients. Standardized psychological screening was used to determine treatment suitability. Evaluation data included the Visual Analog Scale (VAS), Wong-Baker Faces Scale, Brief Pain Inventory (BPI), Disability of Arm, Shoulder, and Hand (DASH), McGill Quality of Life Questionnaire, and complications (granulomas, toxicity, withdrawal, or deaths). SPSS version 18 was used for data analysis. Pre- and post- treatment BPI measures and pain scale scores showed a statistically significant difference. There were no complications directly related to drug toxicity, nor drug withdrawals, granulomas, or deaths. Intrathecal therapy with Sufentanil therapy offers a good treatment alternative for those cases that have failed both surgery and standard pain treatment. Strict patient selection based on psychological screening, control of co-morbidities, a proper pain management may contribute to successful outcome.

Keyword

implantable infusion pump; intractable pain; neuropathic pain; sufentanil

MeSH Terms

Arm
Chronic Pain
Drug-Related Side Effects and Adverse Reactions
Granuloma
Hand
Humans
Infusion Pumps, Implantable
Mass Screening
Neuralgia
Pain Management
Pain, Intractable
Patient Selection
Quality of Life
Surveys and Questionnaires
Shoulder
Statistics as Topic
Sufentanil*
Visual Analog Scale
Sufentanil

Reference

1. Monsivais JJ, Robinson K. Psychological profile and work status of a predominantly Hispanic worker's compensation population with chronic limb pain. Hand (N Y). 2008; 3:352–358. PMID: 18780006.

2. Lieberman IH. Disc bulge bubble: spine economics 101. Spine J. 2004; 4:609–613. PMID: 15541690.

3. Nguyen TH, Randolph DC, Talmage J, Succop P, Travis R. Long-term outcomes of lumbar fusion among workers' compensation subjects: a historical cohort study. Spine (Phila Pa 1976). 2011; 36:320–331. PMID: 20736894.

4. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011; 14:219–248. PMID: 21587327.

5. Waara-Wolleat KL, Hildebrand KR, Stewart GR. A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain. Pain Med. 2006; 7:251–259. PMID: 16712626.

6. Stuppy DJ. The faces pain scale: reliability and validity with mature adults. Appl Nurs Res. 1998; 11:84–89. PMID: 9627435.

7. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008; 9:105–121. PMID: 18055266.